|
| |
| | | 65809 | | 19.05.2015 | | Mepha Pharma AG | | | | | | | | | | | | | 01.01.30. | | | | 01.01.30. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Buprenorphin-Mepha 35ug/h | Transdermale Pflaster | Transdermale Pflaster (Buprenorphine 20 mg) | N02AE01 | IPat | | 02 | Buprenorphin-Mepha 52.5 ug/h | Transdermale Pflaster | Transdermale Pflaster (Buprenorphine 30 mg) | N02AE01 | IPat | | 03 | Buprenorphin-Mepha 70 ug/h | Transdermale Pflaster | Transdermale Pflaster (Buprenorphine 40 mg) | N02AE01 | IPat |
|
|
|
